Anti-amyloidogenic effects of soybean isoflavones in vitro: Fluorescence spectroscopy demonstrating direct binding to Aβ monomers, oligomers and fibrils

Teplow, 1998, Structural and kinetic features of amyloid β-protein fibrillogenesis, Amyloid, 5, 121, 10.3109/13506129808995290 Pike, 1995, Structure-activity analyses of β-amyloid peptides: contributions of the β25–35 region to aggregation and neurotoxicity, J. Neurochem., 64, 253, 10.1046/j.1471-4159.1995.64010253.x Klein, 2004, Small assemblies of unmodified amyloid β-protein are the proximate neurotoxin in Alzheimer's disease, Neurobiol. Aging, 25, 569, 10.1016/j.neurobiolaging.2004.02.010 Klyubin, 2005, Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo, Nat. Med., 11, 556, 10.1038/nm1234 Cheng, 2007, Accelerating amyloid-β fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models, J. Biol. Chem., 282, 23818, 10.1074/jbc.M701078200 Haass, 2007, Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 Walsh, 2007, Aβ oligomers—a decade of discovery, J. Neurochem., 101, 1172, 10.1111/j.1471-4159.2006.04426.x Ono, 2003, Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease, J. Neurochem., 87, 172, 10.1046/j.1471-4159.2003.01976.x Porat, 2006, Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism, Chem. Biol. Drug Des., 67, 27, 10.1111/j.1747-0285.2005.00318.x Ono, 2008, Effects of grape seed-derived polyphenols on amyloid β-protein self-assembly and cytotoxicity, J. Biol. Chem., 283, 32176, 10.1074/jbc.M806154200 Oomen, 2009, Resveratrol preserves cerebrovascular density and cognitive function in aging mice, Front. Aging Neurosci., 1, 4, 10.3389/neuro.24.004.2009 Letenneur, 1993, Wine consumption in the elderly, Ann. Intern. Med., 118, 317, 10.7326/0003-4819-118-4-199302150-00028 Truelsen, 2002, Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study, Neurology, 59, 1313, 10.1212/01.WNL.0000031421.50369.E7 Wang, 2001, The neuroprotective effects of phytoestrogens on amyloid β protein-induced toxicity are mediated by abrogating the activation of caspase cascade in rat cortical neurons, J. Biol. Chem., 276, 5287, 10.1074/jbc.M006406200 Ma, 2010, A large-scale chemical screen for regulators of the arginase 1 promoter identifies the soy isoflavone daidzein as a clinically approved small molecule that can promote neuronal protection or regeneration via a cAMP-independent pathway, J. Neurosci., 30, 739, 10.1523/JNEUROSCI.5266-09.2010 Hirohata, 2007, Anti-amyloidogenic effect against Alzheimer's β-amyloid fibrils in vitro is exerted by preferential and reversible binding of flavonoids to the amyloid fibril structure, Biochemistry, 46, 1888, 10.1021/bi061540x Jarrett, 1993, Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?, Cell, 73, 1055, 10.1016/0092-8674(93)90635-4 Naiki, 1999, Kinetic analysis of amyloid fibril formation, Methods Enzymol., 309, 305, 10.1016/S0076-6879(99)09022-9 Bitan, 2003, Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways, Proc. Natl. Acad. Sci. U. S. A., 100, 330, 10.1073/pnas.222681699 Ono, 2010, Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid β-protein assembly and toxicity, J. Biol. Chem., 285, 23186, 10.1074/jbc.M109.086496 Dufour, 2005, Flavonoid-serum albumin complexation: determination of binding constants and binding sites by fluorescence spectroscopy, Biochim. Biophys. Acta, 1721, 164, 10.1016/j.bbagen.2004.10.013 Radović, 2006, Genistein and other soya isoflavones are potent ligands for transthyretin in serum and cerebrospinal fluid, Br. J. Nutr., 95, 1171, 10.1079/BJN20061779 Adlercreutz, 1994, Determination of lignans and isoflavonoids in plasma by isotope dilution gas chromatography–mass spectrometry, Cancer Detect. Prev., 18, 259 Zeleniuch-Jacquotte, 1998, Reliability of serum measurements of lignans and isoflavonoid phytoestrogens over a two-year period, Cancer Epidemiol. Biomarkers Prev., 7, 885 Doerge, 2002, Goitrogenic and estrogenic activity of soy isoflavones, Environ. Health Perspect., 110, 349S, 10.1289/ehp.02110s3349 Manach, 2005, Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies, Am. J. Clin. Nutr., 81, 230S, 10.1093/ajcn/81.1.230S Youdim, 2004, Flavonoids and the brain: interactions at the blood–brain barrier and their physiological effects on the central nervous system, Free Radic. Biol. Med., 37, 1683, 10.1016/j.freeradbiomed.2004.08.002 Wang, 2008, Grape-derived polyphenolics prevent Aβ oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease, J. Neurosci., 28, 6388, 10.1523/JNEUROSCI.0364-08.2008 Wang, 2012, Brain-targeted proanthocyanidin metabolites for Alzheimer's disease treatment, J. Neurosci., 32, 5144, 10.1523/JNEUROSCI.6437-11.2012 Ma, 2010, Genistein as a neuroprotective antioxidant attenuates redox imbalance induced by β-amyloid peptides 25–35 in PC12 cells, Int. J. Dev. Neurosci., 28, 289, 10.1016/j.ijdevneu.2010.03.003 Vallés, 2008, Oestradiol or genistein rescues neurons from amyloid β-induced cell death by inhibiting activation of p38, Aging Cell, 7, 112, 10.1111/j.1474-9726.2007.00356.x Vallés, 2010, Estradiol or genistein prevent Alzheimer's disease-associated inflammation correlating with an increase PPARγ expression in cultured astrocytes, Brain Res., 1312, 138, 10.1016/j.brainres.2009.11.044 Hsieh, 2009, Soy isoflavones attenuate oxidative stress and improve parameters related to aging and Alzheimer's disease in C57BL/6J mice treated with D-galactose, Food Chem. Toxicol., 47, 625, 10.1016/j.fct.2008.12.026 Gutierrez-Zepeda, 2005, Soy isoflavone glycitein protects against β amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans, BMC Neurosci., 6, 54, 10.1186/1471-2202-6-54